These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 17971769)
21. Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer. Hahn T; Alvarez I; Kobie JJ; Ramanathapuram L; Dial S; Fulton A; Besselsen D; Walker E; Akporiaye ET Int J Cancer; 2006 May; 118(9):2220-31. PubMed ID: 16331615 [TBL] [Abstract][Full Text] [Related]
22. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib. Ferrario A; Lim S; Xu F; Luna M; Gaffney KJ; Petasis NA; Schönthal AH; Gomer CJ Cancer Lett; 2011 May; 304(1):33-40. PubMed ID: 21339042 [TBL] [Abstract][Full Text] [Related]
23. Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions. Zhang LJ; Wang SY; Huo XH; Zhu ZL; Chu JK; Ma JC; Cui DS; Gu P; Zhao ZR; Wang MW; Yu J World J Gastroenterol; 2009 Jun; 15(22):2731-8. PubMed ID: 19522023 [TBL] [Abstract][Full Text] [Related]
24. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus. Zhang L; Bertucci AM; Smith KA; Xu L; Datta SK Arthritis Rheum; 2007 Dec; 56(12):4132-41. PubMed ID: 18050205 [TBL] [Abstract][Full Text] [Related]
25. COX-2 expression in chondrosarcoma: a role for celecoxib treatment? Schrage YM; Machado I; Meijer D; Briaire-de Bruijn I; van den Akker BE; Taminiau AH; Kalinski T; Llombart-Bosch A; Bovée JV Eur J Cancer; 2010 Feb; 46(3):616-24. PubMed ID: 20004565 [TBL] [Abstract][Full Text] [Related]
26. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells. Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393 [TBL] [Abstract][Full Text] [Related]
27. The anti-proliferative potency of celecoxib is not a class effect of coxibs. Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via VEGF-C. Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L Anat Rec (Hoboken); 2009 Oct; 292(10):1577-83. PubMed ID: 19685508 [TBL] [Abstract][Full Text] [Related]
29. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Gupta S; Adhami VM; Subbarayan M; MacLennan GT; Lewin JS; Hafeli UO; Fu P; Mukhtar H Cancer Res; 2004 May; 64(9):3334-43. PubMed ID: 15126378 [TBL] [Abstract][Full Text] [Related]
30. Antitumor properties of taxol in combination with cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian tumor growth in vivo. Li W; Zhai L; Tang Y; Cai J; Liu M; Zhang J Oncol Res; 2012; 20(2-3):49-59. PubMed ID: 23193911 [TBL] [Abstract][Full Text] [Related]
31. Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer. Zhang B; Ma X; Li Z; Gao X; Wang F; Liu L; Shen G; Sang Y; Li M; Li Y; Zhao J; Wei Y J Cancer Res Clin Oncol; 2013 May; 139(5):797-807. PubMed ID: 23385883 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1. Lu ZH; Xiong XY; Zhang BL; Lin GC; Shi YX; Liu ZG; Meng JR; Zhou YM; Mei QB Acta Pharmacol Sin; 2005 Dec; 26(12):1505-11. PubMed ID: 16297351 [TBL] [Abstract][Full Text] [Related]
33. The anti-cancer effect of COX-2 inhibitors on gastric cancer cells. Cho SJ; Kim N; Kim JS; Jung HC; Song IS Dig Dis Sci; 2007 Jul; 52(7):1713-21. PubMed ID: 17393325 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells. Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447 [TBL] [Abstract][Full Text] [Related]
35. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice]. Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672 [TBL] [Abstract][Full Text] [Related]
37. Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord. Tegeder I; Niederberger E; Vetter G; Bräutigam L; Geisslinger G J Neurochem; 2001 Nov; 79(4):777-86. PubMed ID: 11723170 [TBL] [Abstract][Full Text] [Related]
38. Clinical pharmacology of celecoxib, a COX-2 selective inhibitor. Antoniou K; Malamas M; Drosos AA Expert Opin Pharmacother; 2007 Aug; 8(11):1719-32. PubMed ID: 17685888 [TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells. Dhawan D; Jeffreys AB; Zheng R; Stewart JC; Knapp DW Mol Cancer Ther; 2008 Apr; 7(4):897-904. PubMed ID: 18413803 [TBL] [Abstract][Full Text] [Related]
40. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis. Olivares C; Bilotas M; Buquet R; Borghi M; Sueldo C; Tesone M; Meresman G Hum Reprod; 2008 Dec; 23(12):2701-8. PubMed ID: 18716040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]